Modification of the spinal peak growth velocity as a possible treatment for adult scoliosis.
King
Andrew G
AG
Department of Orthopaedics, Pediatric Orthopaedics, Pediatric Spine Surgery, Children's Hospital, Louisiana State University Health Science Center, New Orleans, Louisiana USA. aking@lsuhsc.edu
D000293:Adolescent; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001846:Bone Development / Q000187:drug effects / Q000502:physiology*; D002648:Child; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008297:Male; D011627:Puberty / Q000187:drug effects / Q000502:physiology*; D012307:Risk Factors; D012600:Scoliosis / Q000503:physiopathology / Q000517:prevention & control / Q000601:surgery*; D013131:Spine / Q000254:growth & development*
D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D016729:Leuprolide